Golimumab and certolizumab: The two new anti-tumor necrosis factor kids on the block

Mohit Mittal, Siba P Raychaudhuri

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Golimumab and certolizumab: The two new anti-tumor necrosis factor kids on the block'. Together they form a unique fingerprint.

Medicine & Life Sciences